Summary
Updated Aug 30, 2026
Lori McNeill is Director of Sonnet BioTherapeutics Holdings, Inc. (SONN). 3 SEC Form 4 filings on record going back to 2024, most recently on 3 December 2025.
Recent Transactions
3Every recent SEC Form 4 transaction Lori McNeill has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Lori McNeill's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Daniel Patrick O'Day - $47.86M of GILD open-market activity in the last 12 months
- Roger Adsett - $47.51M of INSM open-market activity in the last 12 months
- Bihua Chen - $46.87M of MLTX open-market activity in the last 12 months
- Mario Schlosser - $46.37M of OSCR open-market activity in the last 12 months
- Matthew Gline - $46.22M of ROIV open-market activity in the last 12 months
- Larry Robbins - $46.04M of BFLY open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Lori McNeill?
Lori McNeill is a corporate insider, tracked as Director of Sonnet BioTherapeutics Holdings, Inc. (SONN). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Lori McNeill last file a Form 4?
The most recent primary Form 4 on record is dated 3 December 2025, one of 3 filings going back to 2024.
Where can I see all of Lori McNeill's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Lori McNeill and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
